A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's Macroglobulinemia

This study is ongoing, but not recruiting participants.

Study NCT00398710 Information provided by Keryx / AOI Pharmaceuticals, Inc.

First Received: November 9, 2006 Last Updated: April 4, 2008 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

Perifosine

Sponsors listed in this trial